150 related articles for article (PubMed ID: 24111708)
1. A survival analysis of GBM patients in the West of Scotland pre- and post-introduction of the Stupp regime.
Teo M; Martin S; Owusu-Agyemang K; Nowicki S; Clark B; Mackinnon M; Stewart W; Paul J; St George J
Br J Neurosurg; 2014 Jun; 28(3):351-5. PubMed ID: 24111708
[TBL] [Abstract][Full Text] [Related]
2. Improved survival of Swedish glioblastoma patients treated according to Stupp.
Bruhn H; Strandéus M; Milos P; Hallbeck M; Vrethem M; Lind J
Acta Neurol Scand; 2018 Oct; 138(4):332-337. PubMed ID: 29882211
[TBL] [Abstract][Full Text] [Related]
3. A Survival Analysis with Identification of Prognostic Factors in a Series of 110 Patients with Newly Diagnosed Glioblastoma Before and After Introduction of the Stupp Regimen: A Single-Center Observational Study.
Illic R; Somma T; Savic D; Frio F; Milicevic M; Solari D; Nikitovic M; Lavrnic S; Raicevic S; Milosevic S; Cavallo LM; Cappabianca P; Grujicic D
World Neurosurg; 2017 Aug; 104():581-588. PubMed ID: 28522381
[TBL] [Abstract][Full Text] [Related]
4. Combined modality treatment of newly diagnosed glioblastoma multiforme in a regional neurosurgical centre.
Gauden AJ; Hunn A; Erasmus A; Waites P; Dubey A; Gauden SJ
J Clin Neurosci; 2009 Sep; 16(9):1174-9. PubMed ID: 19540125
[TBL] [Abstract][Full Text] [Related]
5. Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China.
Wang Y; Zhang J; Li W; Jiang T; Qi S; Chen Z; Kang J; Huo L; Wang Y; Zhuge Q; Gao G; Wu Y; Feng H; Zhao G; Yang X; Zhao H; Wang Y; Yang H; Kang D; Su J; Li L; Jiang C; Li G; Qiu Y; Wang W; Wang H; Xu Z; Zhang L; Wang R
Future Oncol; 2021 Nov; 17(33):4571-4582. PubMed ID: 34519220
[TBL] [Abstract][Full Text] [Related]
6. The validity of EORTC GBM prognostic calculator on survival of GBM patients in the West of Scotland.
Teo M; Clark B; MacKinnon M; Stewart W; Paul J; St George J
Br J Neurosurg; 2014 Jun; 28(3):356-62. PubMed ID: 24111707
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
[TBL] [Abstract][Full Text] [Related]
8. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients.
Oh SW; Jee TK; Kong DS; Nam DH; Lee JI; Seol HJ
Acta Neurochir (Wien); 2014 Apr; 156(4):641-51. PubMed ID: 24553726
[TBL] [Abstract][Full Text] [Related]
9. Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era.
McNamara MG; Lwin Z; Jiang H; Chung C; Millar BA; Sahgal A; Laperriere N; Mason WP
J Neurooncol; 2014 Mar; 117(1):153-60. PubMed ID: 24469855
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy with and without temozolomide in elderly patients with glioblastoma.
Niyazi M; Schwarz SB; Suchorska B; Belka C
Strahlenther Onkol; 2012 Feb; 188(2):154-9. PubMed ID: 22231634
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report.
Biau J; Chautard E; De Schlichting E; Dupic G; Pereira B; Fogli A; Müller-Barthélémy M; Dalloz P; Khalil T; Dillies AF; Durando X; Godfraind C; Verrelle P
Radiat Oncol; 2017 Dec; 12(1):197. PubMed ID: 29212499
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide.
Younis SG; Khedr RA; El-Shorbagy SH
J Egypt Natl Canc Inst; 2016 Mar; 28(1):23-30. PubMed ID: 26682634
[TBL] [Abstract][Full Text] [Related]
13. A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?
Rock K; McArdle O; Forde P; Dunne M; Fitzpatrick D; O'Neill B; Faul C
Br J Radiol; 2012 Sep; 85(1017):e729-33. PubMed ID: 22215883
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma: clinical characteristics, prognostic factors and survival in 492 patients.
Stark AM; van de Bergh J; Hedderich J; Mehdorn HM; Nabavi A
Clin Neurol Neurosurg; 2012 Sep; 114(7):840-5. PubMed ID: 22377333
[TBL] [Abstract][Full Text] [Related]
15. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of concomitant radiotherapy in newly diagnosed glioblastoma multiforme: a multivariate analysis of 116 patients.
Okumus NO; Gursel B; Meydan D; Ozdemir O; Odabas E; Gonullu G
Ann Saudi Med; 2012; 32(3):250-5. PubMed ID: 22588435
[TBL] [Abstract][Full Text] [Related]
17. Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients.
Behm T; Horowski A; Schneider S; Bock HC; Mielke D; Rohde V; Stockhammer F
Clin Neurol Neurosurg; 2013 Oct; 115(10):2142-6. PubMed ID: 23993314
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results.
Salmaggi A; Milanesi I; Silvani A; Gaviani P; Marchetti M; Fariselli L; Solero CL; Maccagnano C; Casali C; Guzzetti S; Pollo B; Ciusani E; Dimeco F
J Neurosurg; 2013 Apr; 118(4):821-9. PubMed ID: 23350777
[TBL] [Abstract][Full Text] [Related]
19. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
Ishikawa E; Muragaki Y; Yamamoto T; Maruyama T; Tsuboi K; Ikuta S; Hashimoto K; Uemae Y; Ishihara T; Matsuda M; Matsutani M; Karasawa K; Nakazato Y; Abe T; Ohno T; Matsumura A
J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up results of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastoma multiforme patients. The importance of MRI information in survival: Single-center experience.
Lukács G; Tóth Z; Sipos D; Csima M; Hadjiev J; Bajzik G; Cselik Z; Semjén D; Repa I; Kovács Á
Ideggyogy Sz; 2018 Mar; 71(3-04):95-103. PubMed ID: 29889468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
